Related Experiment Video
Updated: Apr 17, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Recent advances in the management of resistant hypertension
Athanasios J Manolis1, Manolis S Kallistratos1, Michalis Doumas2
1Asklepeion General Hospital, Cardiology department 1 Vassileos Pavlou Ave Voula, Athens, 16673 Greece.
Abstract:
And suddenly, following the preliminary results of renal denervation and carotid baroreceptor stimulation, a big interest in resistant hypertension rose, and all interventionists, many of them with no previous experience with hypertension, fell in love with hypertension and especially resistant hypertension. In the European Society of Hypertension/International Society of Hypertension (ESH/ISH) 2014 Joint Hypertension meeting in Athens, there were no more than four to five sessions related to resistant hypertension and renal denervation, while in the 2014 EuroPCR meeting there were more than 60 renal denervation sessions! In light of the growing scientific interest in the treatment of this patient group, an update on the treatment available and some concerns regarding the definition and treatment of resistant hypertension is presented.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Heart Failure V: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction

